DAFTAR PUSTAKA
American Cancer Society. 2013. Breast Cancer.
http://www.cancer.org/acs/groups/cid/documents/webcontent/003090-pdf.pdf. 24th Nov 2013.
American Cancer Society. 2013. Tumor Marker.
http://www.cancer.org/acs/groups/cid/documents/webcontent/003189-pdf.pdf. 24th Nov 2013.
Anderson E. Progesterone receptors – animal models and cell signaling in breast
cancer: The role of oestrogen and progesterone receptors in human
mammary development and tumorigenesis. Breast Cancer Res, 4; 197-201.
Armstrong K., Eisen A., and Weber B. 2000. Assessing the Risk of Breast Cancer.
N Engl J Med 342(8); 564-571.
Australian Government. 2013. Breast Cancer Statistics. Cancer Australia.
http://canceraustralia.gov.au/affected-cancer/cancer-types/breast-cancer/breast-cancer statistics. 24th Nov 2013.
Bartel D.P. 2004. MicroRNAs: Genomics, Biogenesis, Mechanism, and Function.
Cell 116; 281–297.
Beger C., Pierce L.N., Kruger M., Marcusson E.G., Robbins J.M., Welcsh P.,
Welch P.J., Welte K., King M.C., Barber J.R., and Wong-Staal F. 2001.
Identification of Id4 as a Regulator of BRCA1 Expression by Using a
Blenkiron C., Goldstein L.D., Thorne N.P., Spiteri I., Chin S.F., Dunning M.J.,
Barbosa-Morais N.L., Teschendorff A.E., Green A.R., Ellis I.O., Tavare S.,
Caldas C., and Miska E.A. 2007. MicroRNA Expression Profiling of Human
Breast Cancer Identifies New Markers of Tumor Subtype. Genome Biology
8(10); R214.1-16.
Bruning U., Cerone L., Neufeld Z., Fitzpatrick S.F., Cheong A, Scholz C.C.,
Simpson D.A. , Leonard M.O., Tambuwala M.M., Cummins E.P., and
Taylor1 C.T. 2011. MicroRNA-155 Promotes Resolution of
Hypoxia-Inducible Factor 1-Activity during Prolonged Hypoxia. Mol Cell Biol
31(19); p. 4087–4096.
Calin GA and Croce CM. 2006.MicroRNA Signatures in Human Cancers. Nature
Rev. Cancer 6; 857-866.
Chen L.J., Lim S.H., Yeh Y.T., Lien S.C., and Chiu J.J. 2012. Roles of
microRNAs in Atherosclerosis and Restenosis. Journal of Biomedical
Science 19(79); 1-13.
Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo
X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C.,
Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J.,
Zen K., Zhang J., and Zhang C. 2008. Characterization of microRNAs in
Serum: a Novel Class of Biomarkers for Diagnosis of Cancer and Other
Clurman B.E. and Hayward W.S. 1989. Multiple Proto-oncogene Activations in
Avian Leukosis Virus-induced Lymphomas: Evidence for Stage-specific
Events. Mol. Cell. Biol 9(6); 2657-2664.
Connor E.B. and Stuenkel C.A. 2001. Hormone Replacement Therapy
(HRT)-Risk and Benefits. Int J of Epidemiology 30; 423-426.
Cortez M.A., Bueso-Ramos C., Ferdin J., Lopez-Berestein G., Sood A.K., and
Calin G.A. 2011. MicroRNAs in Body Fluids—the Mix of Hormones and
Biomarkers. Nat Rev Clin Oncol 8(8); 467–477.
Cronin P.A., Jiang H Wang J.H., and H Paul Redmond H.P. 2010. Hypoxia
increases the metastatic ability of breast cancer cells via upregulation of
CXCR4. BMC Cancer 10(225); 1-8.
Dağlar G., Yuksek Y.N., Gozalan A.U., Tutuncu T., Gungor Y., and Kama N.A.
2010. The Prognostic Value of Histopatological Grade in the Outcome of
Patients with Invasive Breast Cancer. Turk J Med Sci 40(1); 7-15.
Dahlan M.S. 2010. Besar Sampel dan Cara Pengambilan Sampel dalam
Penelitian Kedokteran dan Kesehatan. Edisi 3. Salemba Medika. Jakarta.
de Jong M.M., Nolte I.M., te Meerman G.J., van der Graaf W.T.A., Oosterwijk
J.C., Kleibeuker J.H., Schaapveld M., and de Vries E.G.E. 2002. Genes
Other than BRCA1 and BRCA2 Involved in Breast Cancer Susceptibility. J
Med Genet 39; 225–242.
DEPKES RI. 2009. Pencegahan Kanker Leher Rahim dan Kanker Payudara.
http://www.pppl.depkes.go.id/_asset/_download/bukusaku_kanker.pdf. 10
Duffy M.J. and McGing P. 2010. Guidelines for the use of Tumour Markers. 4th
edition. Association of Clinical Biochemists in Ireland.
Ergul E. and Sazci A. 2001. Molecular Genetics of Breast Cancer. Turk J Med Sci
31; 1-14.
Esteller M. 2011.Non-coding RNAs in human disease. Nature 12; 861-874.
Friedman R.C., Farh K.K.H., Burge C.B., Bartel D.P. 2009. Most Mammalian
mRNAs are Conserved Targets of microRNAs. Genome Research 19; 92–
105.
Gasco M., Shami S. and Crook T. 2002. The p53 Pathway in Breast Cancer.
Breast Cancer Res 4; 70-76.
Grazio S.F. and Bracko M. 2002. Long term Prognostic Value of Nottingham
Histopatological Grade and its Components in Early (pT1N0M0) Breast
Carcinoma. J Clin Pathol 55; 88–92.
Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. 2005. Human RISC
Couples microRNA Biogenesis and Posttranscriptional Gene Silencing. Cell
123; 631–640.
Hall J.M., Lee M.K., Newman B., Morrow J.E., Anderson L.A., Huey B., and
King M.C. 1990. Linkage of Early-onset Familial Breast Cancer to
Chromosome 17q21. Science 250; 1684-1689.
Han J., Lee Y., Yeom K.H. 2006. Molecular Basis for the Recognition of Primary
microRNAs by the Drosha-DGCR8 Complex. Cell 125; 887–901.
Harris L., Fritsche H., Mennel R., Norton L., Ravdin P., Taube S., Somerfield
Oncology 2007 Update of Recommendations for the Use of Tumor Markers
in Breast Cancer. J Clin Oncol 25; 5287-5312.
Hauptman N. and Glavac D. 2013. MicroRNAs and Long Non-coding RNAs:
Prospects in Diagnostics and Therapy of Cancer. Radiol Oncol 47(4);
311-318.
Hedenfalk I.A., Ringner M., Trent J.M., and Borg A. 2002. Gene Expression in
Inherited Breast Cancer. Advances in Cancer Research 84; 1-34.
He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S.,
Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., and Hammond S.M.
2005. A microRNA Polycistron as a Potential Human Oncogen. Nature 435;
828-833.
He L., Long L.R., Antani S., Thoma G.R. Computer assisted diagnosis in
histopathology. Chapter 15. National Institutes of Health, USA.
http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1
&cad=rja&uact=8&ved=0CCUQFjAA&url=http%3A%2F%2Ficonceptpre
ss.com%2Fdownload%2Fpaper%2F100531205733.pdf&ei=klhNU7LvEsa_
rgeZ6oGYAg&usg=AFQjCNFfUPakWNN4FzjVNT6NRxpKCgBW6g&bvm=
bv.64764171,d.bmk. 18th Feb 2014.
Henry N.L. and Hayes D.F. 2006. Uses and Abuses of Tumor Markers in the
Diagnosis, Monitoring, and Treatment of Primary and Metastatic Breast
Cancer. The Oncologist 11; 541-552.
Hui A., How C., Ito E., and Liu F. 2011. Micro-RNAs as Diagnostic or Prognostic
Huntzinger E., Izaurralde E. 2011. Gene Silencing by microRNAs: Contributions
of Translational Repression and mRNA Decay. Nature 12; 99-110.
Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., Magri E.,
Pedriali M., Fabbri M., Campiglio M., Me´nard S., Palazzo J.P., Rosenberg
A, Musiani P., Volinia S., Nenci I., Calin G.A., Querzoli P., Negrini M., and
Croce C.M. 2005. MicroRNA Gene Expression Deregulation in Human
Breast Cancer. Cancer Res 65 (16); 7065-7070.
Kon W., 2010. The Role of MicroRNA-155 in Human Breast Cancer.
Dissertation. the degree of Doctor of Philosophy Department of Pathology
and Cell Biology College of Medicine University of South Florida.
Kumar V., Cotran R.S., dan Robbins SL. 2007. Buku Ajar Patologi Robbins.
Sistem genitalia perempuan dan payudara: Payudara. Edisi 7. EGC.
Jakarta.
Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., and Tuschl T.
2002. Identification of Tissue-Specific MicroRNAs from Mouse. Current
Biology 12; 735–739.
Lee I., Cook N.R., Rexrode K.M., and Buring J.E. 2001. Lifetime physical
activity and risk of breast cancer. British Journal of Cancer 85(7); 962–965.
Lee R.C., Feinbaum R.L., Ambros V. 1993. The C. elegans Heterochronic Gene
lin-4 Encodes Small RNAs with Antisense Complementarity to lin-14. Cell
Lee Y.H., Bedford M.T., and Stallcup M.R. 2011. Regulated recruitment of tumor
suppressor BRCA1 to the p21 gene by coactivator methylation. Genes Dev
25; 176-188.
Loman N., Bladström A., Johannsson O., Borg A., and Olsson H. 2003. Cancer
incidence in relatives of a population-based set of cases of early-onset breast
cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer
Res 5; R175-R186.
Lu Z., Ye Y., Jiao D., Qiao J., Cui S., and Liu Z. 2012. miR-155 and miR-31 are
differentially expressed in breast cancer patients and are correlated with the
estrogen receptor and progesterone receptor status. Oncology Letters 4;
1027-1032.
Mandal A. 2013. Breast Cancer Epidemiology.
http://www.news-medical.net/health/Breast-Cancer-Epidemiology.aspx. 24th Nov 2013.
Mar-Aguilar F., Mendoza-Ram´ırez J.A., Malag´on-Santiago I., Espino-Silva
P.K., Santuario-Facio S.K., Ruiz-Flores P., Rodr´ıguez-Padilla C., and
Res´endez-P´erez D. 2013. Serum circulating microRNA profiling for
identification of potential breast cancer biomarkers. Disease Markers 34;
163–169.
Martinez-Sanchez A., Murphy C.L. 2013. MicroRNA Target
Identification-Experimental Approaches. Biology 2; 189-205.
Mattiske S., Suetani R.J, Neilsen P.M., Callen D.F. 2012. Cancer Epidemiol
American Association for Cancer Research. cebp.aacrjournals.org. 4th Sept
2013.
Massagué J. 2008. TGFβ in Cancer. Cell 134; 215-230.
McTiernan A., Rajan K.B., Tworoger S.S., Irwin M., Bernstein L., Baumgartner
R., Gilliland F., Stanczyk F.Z., Yasui Y., and Ballard-Barbash R. 2003.
Adiposity and Sex Hormones in Postmenopausal Breast Cancer Survivors. J
Clin Oncol 21; 1961-1966.
Mendes N.D., Freitas A.T., Sagot M.F. 2009. Current tools for the identification
of miRNA genes and their target. Nucleic Acids Research 37 (8); 2419–
2433.
Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian
S., Liu Q., Cochran C., Bennett L.M., Ding W., Bell R., Rosenthal J.,
Hussey C., Tran T., McClure M., Frye C., Hattier T., Phelps R.,
Haugen-Strano A., Katcher H., Yakumo K., Gholami Z., Shaffer D., Stone S., Bayer
S., Wray C., Bogden R., Dayananth P., Ward J., Tonin P., Narod S., Bristow
P.K., Norris F.H., Helvering L., Morrison P., Rosteck P., Lai M., Barrett
J.C., Lewis C., Neuhausen S., Cannon-Albright L., Goldgar D., Wiseman R.,
Kamb A., and Skolnick M.H. 1994. A Strong Candidate for the Breast and
Ovarian Cancer Susceptibility Gene BRCA1. Science 266; 66-71.
Mukherjee D. and Zhao J. 2013. The Role of chemokine receptor CXCR4 in
breast cancer metastasis. Am J Cancer Res 3(1); 46-57.
Oakley K.L. and Going J.J. 1995. Specimen Slice Radiography of Cancer in
Oemiati R., Rahajeng E., Kristanto A.Y. 2011. Prevalensi Tumor dan beberapa
faktor yang Mempengaruhinya di Indonesia. Bul. Penelit. Kesehat 39(4);
190 – 204.
Ostad S.N. and Parsa M. 2011. Breast Cancer from Molecular Point of View:
Pathogenesis and Biomarkers. Chapter 6. Faculty of Pharmacy, Tehran
University of Medical Sciences. Tehran.
http://cdn.intechopen.com/pdfs-wm/24879.pdf. 10th Apr 2014.
Ozsolak F., Poling L.L., Wang Z., Liu H., Liu X.S., Roeder R.G., Zhang X., Song
J.S., Fisher D.E. 2008. Chromatin structure analyses identify miRNA
promoters. Genes Dev 22; 3172-3183.
Pöschl G. and Seitz H.K. 2004. Alcohol and Cancer. Alcohol & Alcoholism 39(3);
pp.155–165.
Rakha E.A., Reis-Filho J.S., Baehner F., Dabbs D.J., Decker T., Eusebi V., Fox
S.B., Ichihara S., Jacquemier J., Lakhani S.R., Palacios J., Richardson A.L.,
Schnitt S.J., Schmitt F.C., Tan P., Tse G.M., Badve S., and Ellis I.O. 2010.
Breast cancer prognostic classifi cation in the molecular era: the role of
histopatological grade. Breast Cancer Research 12; 207.p1-12.
Reinhart, B.J., Slack, F.J., Basson, M., Pasquinelli, A.E., Bettinger, J.C., Rougvie,
A.E., Horvitz, H.R., and Ruvkun, G. 2000. The 21- nucleotide let-7 RNA
regulates developmental timing in Caenorhabditis elegans. Nature 403;
Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. 2004. Identification of
mammalian microRNA host genes and transcription units. Genome Res 14;
1902–1910.
Saini H.K., Griffiths-Jones S., Enright A.J. 2007. Genomic analysis of human
microRNA transcripts. Proc Natl Acad Sci USA 104; 17719–17724.
Sen C.K., Gordillo G.M., Khanna S., Roy S. 2009. Micromanaging Vascular
Biology: Tiny MicroRNAs Play Big Band. J Vasc Res 46; 527–540.
SHEN G, LI X, JIA Y,PIAZZA G.A., and XI Y. 2013. Hypoxia-regulated
microRNAs in human cancer. Acta Pharmacologica Sinica 34; 336–341.
Sjamsuhidajat R. dan de Jong W. 2004. Buku Ajar Ilmu Bedah. Tindakan bedah
organ dan sistem organ: Payudara. Edisi 2. EGC. Jakarta.
Stefansson O.A. and Esteller M. 2012. BRCA1 as a tumor suppressor linked to
the regulation of epigenetic states: keeping oncomiRs under control. Breast
Cancer Research 14; 304.
Szafranska A.E., Davison T.S., Shingara J., Doleshal M., Riggenbach J.A.,
Morrison C.D., Jewell S., and Labourier E. 2008. Accurate Molecular
Characterization of Formalin-Fixed, Paraffin-Embedded Tissues by
microRNA Expression Profiling. JMD 10(5); 415-423.
Taghian AG, Smith BL, Erban JK. 2010. Breast Cancer: A Multidisciplinary
Approach to Diagnosis and Management. Demos Medical. New York.
Tavassoli F.A and Devilee P. 2003. Pathology and Genetics: Tumours of the
Breast and Female Genital Organs. WHO Classification of Tumours;5.
Terry P.D. and Rohan T.E. 2002. Cigarette Smoking and the Risk of Breast
Cancer in Women: A Review of the Literature. Cancer Epidemiol
Biomarkers Prev 11;953-971.
Tryggvadottir L., Olafsdottir E.J., Gudlaugsdottir S., Thorlacius S., Jon G.,
Jonasson J.G., Tulinius H., and Eyfjord J.E. 2003. BRCA2 mutation carriers,
reproductive factors and breast cancer Risk. Breast Cancer Res 5;
R121-R128.
Valencia-Sanchez M.A.V., Liu J., Hannon G.J., Parker R. 2006. Control of
translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20;
515-524.
Volinia S., Calin G.A., Liu C., Ambs S., Cimmino A., Petrocca F., Visone R.,
Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G.,
Scarpa A., Vecchione A., Negrini M., Harris C.C., and Croce C.M. 2006. A
microRNA expression signature of human solid tumors defines cancer gene
targets. PNAS 103(7); 2257-2261.
Wang F., Zhiguo Zheng Z., Guo J., and Ding X. 2010. Correlation and
quantitation of microRNA aberrant expression in tissues and sera from
patients with breast tumor. Gynecol Oncol doi: 10.1016 /j.ygyno.
2010.07.021; 1-8.
Weir H.K., Thun M.J., Hankey B.F., Ries L.A.G., Howe H.L., Wingo P.A., Jemal
A., Ward E., Anderson R.N., Edwards B.K. 2003. Annual Report to the
Surveillance Data for Cancer Prevention and Control. J Natl Cancer Inst
95(17); 1276-1299.
WHO. 2013. Breast cancer: prevention and control.
http://www.who.int/cancer/detection/breastcancer/en/. 24th Nov 2013.
Wrensch M., Chew T., Farren G., Barlow J., Belli F., Clarke C., Erdmann C.A.,
Lee M., Moghadassi M., Peskin-Mentzer R., Quesenberry Jr C.P.,
Souders-Mason V., Spence L., Suzuki M. and Gould M. 2003. Risk factors for breast
cancer in a population with high incidence rates. Breast Cancer Res 5;
R88-R102.
Xia W., Cao G.J., Shao N.S. 2009. Progress in miRNA target prediction and
identification. Sci China Ser C-Life Sci 52(12); 1123-1130.
Zhao S.Y., Wu Q., Gao F., Zhang C.B., and Yang X.W. 2012. Serum
microRNA-155 as a potential biomarker for breast cancer screening. Chin Sci Bull 57;
3466-3468.
Zheng W., Zou H., Tan Y., Cai W. 2011. Identification of MicroRNA Target
Genes in Vivo. Mol Biotechnol 47; 200–204.
Zhu W., Qin W., Atasoy, Sauter E.R. 2009. Circulating microRNAs in breast